Inside India’s textile factories training AI robots
In a textile factory, workers are doing more than stitching and packing garments... they’re helping train AI.
AIIMS Delhi to begin screening children aged 2-18 years for Covaxin trials from today
New Delhi,UPDATED: Jun 7, 2021 11:37 IST
After All India Institute of Medical Sciences Patna recently began the vaccine trail for children aged between 12 and 18 years, the Delhi AIIMS on Monday started screening children for the clinical trials of Covaxin, the indigenous Covid-19 vaccine developed by Bharat Biotech and ICMR. A total of 525 children will be included in these clinical trials of Covaxin, who will be divided into three groups. The first group will have 175 children aged between 12 and 18 years while the second group will have 175 children aged between 6 and 12 years. Group 3 will have another 175 children aged between 2 and 6 years. Watch the video to find out more.
Read More
LATEST VIDEOS
Why Aishwarya Rai is Cannes royalty
Aishwarya Rai Bachchan finally arrived at Cannes 2026 and instantly took over the internet.
Post-mortem: NEET-UG paper leak exposes systemic failure, coaching nexus in India
The National Testing Agency (NTA) cancelled the NEET UG 2026 examination after a massive paper leak was uncovered, affecting over twenty-two lakh medical aspirants across the country.
Health 360: Delhi heatwave causes explained; truth about sunscreens revealed
This episode of Health 360 explores the severe heatwave conditions in Delhi and other urban centres, highlighting how the degradation of the Aravalli forests and the South Central Ridge contributes to rising temperatures.